The 19 analysts offering 12-month price forecasts for Sanofi SA have a median target of 62.50, with a high estimate of 65.35 and a low estimate of 50.26. The median estimate represents a +17.50% increase from the last price of 53.19.
The current consensus among 22 polled investment analysts is to Buy stock in Sanofi SA. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.71
Reporting Date TBD
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.